艾迪康控股（09860）今日盘中大跌5.72%，引发市场关注。此次股价下跌主要源于公司发布的2024年度业绩公告显示业绩大幅下滑。
根据公告，艾迪康控股2024年度实现营业收入29.14亿元，同比下降11.6%；归属于母公司股东的净利润为4701.4万元，同比大幅下降78.7%。公司业绩下滑主要受新冠相关检测收入锐减影响，尽管常规检测业务（不含新冠）同比增长8.2%，特检业务收入增长18%，共建业务增长62%，但仍无法弥补新冠检测业务收入的大幅下降。
值得注意的是，艾迪康控股董事会决定不派发2024年度股息，这可能进一步打击了投资者信心。分析人士认为，公司业绩的大幅下滑以及取消派息的决定是导致股价下跌的主要原因，投资者对公司未来盈利能力的担忧也反映在了股价表现上。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.